Cargando…

From Innate Immunity to Metabolic Disorder: A Review of the NLRP3 Inflammasome in Diabetes Mellitus

The role of the NLRP3 inflammasome is pivotal in the pathophysiology and progression of diabetes mellitus (DM), encompassing both type 1 (T1D), or type 2 (T2D). As part of the innate immune system, NLRP3 is also responsible for the chronic inflammation triggered by hyperglycemia. In both conditions,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nițulescu, Iris Maria, Ciulei, George, Cozma, Angela, Procopciuc, Lucia Maria, Orășan, Olga Hilda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531881/ https://www.ncbi.nlm.nih.gov/pubmed/37762961 http://dx.doi.org/10.3390/jcm12186022

Ejemplares similares

Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies
por: ORASAN, OLGA HILDA, et al.
Publicado: (2016)

MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis
por: Fodor, Adriana, et al.
Publicado: (2021)

Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
por: Di Stefano, Antonino, et al.
Publicado: (2014)

Paclitaxel Enhances the Innate Immunity by Promoting NLRP3 Inflammasome Activation in Macrophages
por: Zeng, Qiong-zhen, et al.
Publicado: (2019)

NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases
por: Zhang, Yiwen, et al.
Publicado: (2021)

The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity
por: Papadakos, Stavros P., et al.
Publicado: (2022)

Diagnostic Performance of Serum Biomarkers Fibroblast Growth Factor 21, Galectin-3 and Copeptin for Heart Failure with Preserved Ejection Fraction in a Sample of Patients with Type 2 Diabetes Mellitus
por: Ianoș, Raluca D., et al.
Publicado: (2021)

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
por: Shen, Yao, et al.
Publicado: (2022)

Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders
por: Wani, Kaiser, et al.
Publicado: (2021)

The Role of the Interplay Between Autophagy and NLRP3 Inflammasome in Metabolic Disorders
por: Lv, Shuangyu, et al.
Publicado: (2021)

Suppression of Ribosomal Function Triggers Innate Immune Signaling through Activation of the NLRP3 Inflammasome
por: Vyleta, Meghan L., et al.
Publicado: (2012)

TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles)
por: Xing, Y, et al.
Publicado: (2016)

Inflammasome-Independent Role for NLRP3 in Controlling Innate Antihelminth Immunity and Tissue Repair in the Lung
por: Chenery, Alistair L., et al.
Publicado: (2019)

The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
por: Benetti, Elisa, et al.
Publicado: (2013)

NLRP3 Inflammasome and Pathobiology in AMD
por: Celkova, Lucia, et al.
Publicado: (2015)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging
por: Meyers, Allison K., et al.
Publicado: (2020)

NLRP3 Inflammasome: From Pathophysiology to Therapeutic Target in Major Depressive Disorder
por: Kouba, Bruna R., et al.
Publicado: (2022)

Mycotoxin Zearalenone Attenuates Innate Immune Responses and Suppresses NLRP3 Inflammasome Activation in LPS-Activated Macrophages
por: Lee, Po-Yen, et al.
Publicado: (2021)

DNA Methylation and Micro-RNAs: The Most Recent and Relevant Biomarkers in the Early Diagnosis of Hepatocellular Carcinoma
por: Cozma, Angela, et al.
Publicado: (2019)

Association between polymorphisms of genes involved in the Renin-Angiotensin-Aldosterone System and the adaptive morphological and functional responses to essential hypertension
por: Mocan, Oana, et al.
Publicado: (2021)

Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition
por: de Carvalho, Renan V. H., et al.
Publicado: (2019)

Oxidative metabolism enables Salmonella evasion of the NLRP3 inflammasome
por: Wynosky-Dolfi, Meghan A., et al.
Publicado: (2014)

NLRP3 Inflammasome in Metabolic-Associated Kidney Diseases: An Update
por: Xiong, Wei, et al.
Publicado: (2021)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

NLRP3 Inflammasome and Mineralocorticoid Receptors Are Associated with Vascular Dysfunction in Type 2 Diabetes Mellitus
por: Ferreira, Nathanne Santos, et al.
Publicado: (2019)

The NLRP3 Inflammasome in Age-Related Cerebral Small Vessel Disease Manifestations: Untying the Innate Immune Response Connection
por: Che Mohd Nassir, Che Mohd Nasril, et al.
Publicado: (2023)

Role of Innate Immunity in Diabetes and Metabolism: Recent Progress in the Study of Inflammasomes
por: Lee, Myung-Shik
Publicado: (2011)

The role of NLRP3 inflammasome for microglial response to peripheral inflammation
por: Garaschuk, Olga
Publicado: (2020)

Soluble Uric Acid Activates the NLRP3 Inflammasome
por: Braga, Tarcio Teodoro, et al.
Publicado: (2017)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities
por: Ortega, Miguel A., et al.
Publicado: (2023)

Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
por: Zhou, Keren, et al.
Publicado: (2016)

The Role of Endoplasmic Reticulum Stress and NLRP3 Inflammasome in Liver Disorders
por: Lu, Xueqin, et al.
Publicado: (2022)

No NLRP3 Inflammasome Expression in the Ouabain Animal Model of Bipolar Disorder
por: Farooqui, Ali A, et al.
Publicado: (2022)

The NLRP3 inflammasome as a new target in respiratory disorders treatment
por: Leszczyńska, Katarzyna, et al.
Publicado: (2022)

Microglia NLRP3 Inflammasome and Neuroimmune Signaling in Substance Use Disorders
por: Guo, Ming-Lei, et al.
Publicado: (2023)

The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models
por: Palumbo, Laura, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ddt53hng2ncep20er5adrk7lot